dr. mims on waiting for molecular tests before starting therapy in aml
Published 4 years ago • 84 plays • Length 1:01Download video MP4
Download video MP3
Similar videos
-
0:54
dr. mims on performing molecular profiling at diagnosis in aml
-
0:52
dr. mims on the emergence of targeted therapy in aml
-
5:59
debating an algorithm for molecular testing in aml
-
1:14
dr. mims on fda approval of ivosidenib in patients with aml
-
7:31
molecular testing for aml
-
1:14
dr. mims on the beat aml master trial in aml
-
1:16
dr. mims on developed mutations in aml
-
47:56
aml diagnosis and treatment 2022
-
1:01:48
know your aml therapy: venetoclax | dr. alice mims #aml
-
3:59
understanding risk in aml: how molecular testing affects treatment options
-
21:43
clinical use of molecular mrd testing in aml
-
1:17
dr. uy on therapy selection in acute myeloid leukemia
-
10:18
best practices for ngs testing in aml
-
5:53
therapeutic approaches based on mutations in aml
-
4:12
what does triplet therapy in aml mean for the future?
-
1:04
dr. schiller on the importance of genomic testing in aml
-
3:16
how molecular testing has transformed aml treatment options
-
1:27
dr. perl on choosing the optimal therapy in aml
-
1:20
dr. sekeres on the need for novel combinations in higher-risk mds/cmml and low-blast aml